Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

IGOS is a global, prospective, observational, multicenter cohort study that has enrolled ~2000 patients who were followed for one to three years.

Next Previous
Trial Profile

IGOS is a global, prospective, observational, multicenter cohort study that has enrolled ~2000 patients who were followed for one to three years.

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 18 May 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tanruprubart (Primary)
  • Indications Guillain-Barre syndrome
  • Focus Registrational; Therapeutic Use
  • Acronyms IGOS
  • Sponsors Annexon

Most Recent Events

  • 12 May 2025 According to an Annexon media release, FDA meeting with the Center for Drug Evaluation and Research (CDER) scheduled for the second quarter of 2025 ahead of planned BLA submission.
  • 16 Dec 2024 According to an Annexon media release, the company will hold a conference call and webcast today at 8:30 a.m. ET to discuss topline results from its real-world evidence (RWE) study in GBS.
  • 16 Dec 2024 Results presented in an Annexon media Release

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top